Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Somatostatin sst2 agonists synthesized at Merck & Co.

Nov. 27, 1998

Cerus makes steady progress with platelet pathogen inactivation system

Nov. 27, 1998

NE reuptake inhibitor from Lilly shows antiobesity activity in animal models

Nov. 27, 1998

Agents for diabetes and related disorders developed by Dr. Reddy's team

Nov. 26, 1998

Generex receives FDA approval to begin human trials of oral insulin formulation

Nov. 26, 1998

New study will assess troglitazone in the prevention of IGT

Nov. 26, 1998

FDA and Pfizer revise labeling for Viagra, issue updated information

Nov. 25, 1998

Ergo Science receives unapprovable letter from FDA for Ergoset

Nov. 25, 1998

Heterocyclic hypoglycemic agents from SB for diabetes and related disorders

Nov. 24, 1998

Merck & Co. investigates sulfonamides as beta3-agonists with therapeutic potential in obesity

Nov. 23, 1998

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...